Global Pre-Clinical Imaging Market – Industry Analysis and Forecast (2019-2026) _ by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes), and Geography


Global Pre-Clinical Imaging Market is expected to reach USD 1,123.40 Million by 2026 from USD XX  Million in 2018 at CAGR of XX % (Detailed analysis of the market CAGR is provided in the report)



To know about the Research Methodology:-Request Free Sample Report

Global Pre-Clinical Imaging Market imaging systems helps in the monitoring and visualization of animals with respect to cells, tissues, organ, physiological changes and environmental changes taking place inside the animal body. The utilization of small animal models in preclinical studies is a major cornerstone for research and development techniques also pre-clinical imaging technique is filling the gap between the discoveries at molecular level and clinical trials level. The Global Pre-Clinical Imaging Market system market is driven by increasing prevalence of different diseases, rising number of pre-clinical imaging systems in in vivo research along with increasing investments by CRO, pharmaceutical industries & biotechnology industries.

Global Pre-Clinical Imaging Market is segmented by modality, reagent and geography. Modality segment is sub segmented as Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging. Reagent segment is bifurcated as Optical Imaging Reagents, Contrast Agents, PET Tracers, and SPECT Probes. The market based on geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America.

Several factors such as the technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the preclinical imaging market. North America is expected to dominate the Global Pre-Clinical Imaging Market in forecast period followed by Europe and APAC. North America had the highest market due to heavy investments in research and development, highly developed research infrastructure, adoption of advanced technologies and favorable reimbursement policies.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

The years that have been considered for the study are:

• Base year – 2018
• Estimated year – 2019
• Forecast period – 2019 to 2026

 Global Pre-Clinical Imaging Market, Key Highlights:

• Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for Global Pre-Clinical Imaging Market during the forecast period
• Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities
• In-depth analysis of the industry based on market segments, market dynamics, market size, competition & companies involved value chain
• Global Pre-Clinical Imaging Market analysis and comprehensive segmentation with respect to the modality, reagent, and geography to assist in strategic business planning
• Global Pre-Clinical Imaging Market analysis and forecast for five major geographies North America, Europe, Asia pacific, Middle East & Africa, Latin America and their key regions

 Global Pre-Clinical Imaging Market, Research Methodology:

The Global Pre-Clinical Imaging Market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get unbiased idea of the Global Pre-Clinical Imaging Market. This exercise was done at country level to get fair idea of the market in countries considered for this study. Later this country specific data was accumulated to come up with regional numbers and then arrive at global market value for Global Pre-Clinical Imaging Market.

The objective of the report is to present comprehensive Global Pre-Clinical Imaging Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Pre-Clinical Imaging Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Pre-Clinical Imaging Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pre-Clinical Imaging Market  North America for Asia Pacific make the report investor’s guide.

Key Players in the Global Pre-Clinical Imaging Market Are:

• Aspect Imaging Ltd
• Bruker Corporation
• Fujifilm Holdings Corporation
• Li-Cor Biosciences
• Mediso Ltd
• Milabs BV
• Miltenyi Biotec GmbH
• MR Solutions Ltd
• PerkinElmer Inc.
• Trifoil Imaging
• Bioscan
• Mediso Medical Imaging Systems
• Siemens Healthcare
• Thermo Fisher Scientific
• Agilent Technologies
• Capintec
• Hitachi Medical
• Naviscan
• Positron
• Promega
• Berthold Technologies
• INDEC BioSystems
• Hitachi Medical
• Angstrom Advanced Inc.
• Kubtec X-Ray

 Global Pre-Clinical Imaging Market, Key Target Audience:

• Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies
• Pre-Clinical Imaging Research Centres
• Pre-Clinical Imaging Products Manufacturers
• Pre-Clinical Imaging Products Distributors
• Contract research organizations (CROs)
• Government Bodies

Scope of the Global Pre-Clinical Imaging Market: Inquire before buying 

Research report categorizes the Global Pre-Clinical Imaging Market based on modality, reagent, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Pre-Clinical Imaging Market with key developments in companies and market trends.

Global Pre-Clinical Imaging Market, By Modality:

• Optical Imaging
• PET
• SPECT
• CT
• MRI
• Ultrasound
• Photoacoustic Imaging
• Magnetic Particle Imaging

Global Pre-Clinical Imaging Market, By Reagents:

• Optical Imaging Reagents
• Contrast Agents
• PET Tracers
• SPECT Probes

Global Pre-Clinical Imaging Market, By Geography:

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Available Customization:

Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.

  




1. EXECUTIVE SUMMARY
2. RESEARCH METHODOLOGY
2.1. Market Definition
2.2. Market Scope
2.3. Data Sources
3. MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. END-USER OVERVIEW
4.1. Value Chain Analysis
5. GLOBAL PRE-CLINICAL IMAGING MARKET, BY MODALITY (2019-2026)
5.1. Introduction
5.2. Optical Imaging
5.2.1. Optical Imaging Market Overview
5.2.2. Optical Imaging Market Size & Forecast
5.3. PET
5.3.1. PET Market Overview
5.3.2. PET Market Size & Forecast
5.4. SPECT
5.4.1. SPECT Market Overview
5.4.2. SPECT Market Size & Forecast
5.5. CT
5.5.1. CT Market Overview
5.5.2. CT Market Size & Forecast
5.6. MRI
5.6.1. MRI Market Overview
5.6.2. MRI Market Size & Forecast
5.7. Ultrasound
5.7.1. Ultrasound Market Overview
5.7.2. Ultrasound Market Size & Forecast
5.8. Photoacoustic Imaging
5.8.1. Photoacoustic Imaging Market Overview
5.8.2. Photoacoustic Imaging Market Size & Forecast
5.9. Magnetic Particle Imaging
5.9.1. Magnetic Particle Imaging Market Overview
5.9.2. Magnetic Particle Imaging Market Size & Forecast
5.10. Modality Key Trends
6. GLOBAL PRE-CLINICAL IMAGING MARKET, BY REAGENTS (2019-2026)
6.1. Introduction
6.2. Optical Imaging Reagents
6.2.1. Optical Imaging Reagents Market Overview
6.2.2. Optical Imaging Reagents Market Size & Forecast
6.3. Contrast Agents
6.3.1. Contrast Agents Market Overview
6.3.2. Contrast Agents Market Size & Forecast
6.4. PET Tracers
6.4.1. PET Tracers Market Overview
6.4.2. PET Tracers Market Size & Forecast
6.5. SPECT Probes
6.5.1. SPECT Probes Market Overview
6.5.2. SPECT Probes Market Size & Forecast
6.6. Reagents Type Key trends
7. GLOBAL PRE-CLINICAL IMAGING MARKET, BY GEOGRAPHY (2019-2026)
7.1. North America Pre-Clinical Imaging Market
7.1.1. North America Pre-Clinical Imaging Market, By Modality
7.1.2. North America Pre-Clinical Imaging Market, By Reagents
7.1.3. North America Pre-Clinical Imaging Market, by Region
7.1.3.1. U.S. Pre-Clinical Imaging Market
7.1.3.2. Canada Pre-Clinical Imaging Market
7.1.3.3. Mexico Pre-Clinical Imaging Market
7.1.4. North America Pre-Clinical Imaging Market, Key Trends
7.2. Europe Pre-Clinical Imaging Market
7.2.1. Europe Pre-Clinical Imaging Market, By Modality
7.2.2. Europe Pre-Clinical Imaging Market, By Reagents
7.2.3. Europe Global Pre-Clinical Imaging Market, by Region
7.2.3.1. France Pre-Clinical Imaging Market
7.2.3.2. Germany Pre-Clinical Imaging Market
7.2.3.3. U.K. Pre-Clinical Imaging Market
7.2.3.4. Italy Pre-Clinical Imaging Market
7.2.3.5. Spain Pre-Clinical Imaging Market
7.2.3.6. Rest of Europe Pre-Clinical Imaging Market
7.2.4. Europe Pre-Clinical Imaging Market, Key Trends
7.3. Asia Pacific Pre-Clinical Imaging Market
7.3.1. Asia-Pacific Pre-Clinical Imaging Market, By Modality
7.3.2. Asia-Pacific Pre-Clinical Imaging Market, By Reagents
7.3.3. Asia-Pacific Pre-Clinical Imaging Market, by Region
7.3.3.1. China Pre-Clinical Imaging Market
7.3.3.2. Japan Pre-Clinical Imaging Market
7.3.3.3. India Pre-Clinical Imaging Market
7.3.3.4. South Korea Pre-Clinical Imaging Market
7.3.3.5. Rest of Asia Pacific Pre-Clinical Imaging Market
7.3.4. Asia-Pacific Pre-Clinical Imaging Market, Key Trends
7.4. Middle East & Africa Pre-Clinical Imaging Market
7.4.1. Middle East & Africa Pre-Clinical Imaging Market, By Modality
7.4.2. Middle East & Africa Pre-Clinical Imaging Market, By Reagents
7.4.3. Middle East & Africa Pre-Clinical Imaging Market, by Region
7.4.3.1. South Africa Pre-Clinical Imaging Market
7.4.3.2. Rest of Middle East and Africa Pre-Clinical Imaging Market
7.4.4. Middle East & Africa Pre-Clinical Imaging Market, Key Trends
7.5. Latin America Pre-Clinical Imaging Market
7.5.1. Latin America Pre-Clinical Imaging Market, By Modality
7.5.2. Latin America Pre-Clinical Imaging Market, By Reagents
7.5.3. Latin America Pre-Clinical Imaging Market, by Region
7.5.3.1. Brazil Pre-Clinical Imaging Market
7.5.3.2. Rest of Latin America Pre-Clinical Imaging Market
7.5.4. Latin America Pre-Clinical Imaging Market, Key Trends
8. MARKET COMPETITION ANALYSIS
8.1 Market Share/Positioning Analysis
8.2 Key Innovators
8.3 Company Profiles
8.3.1 Aspect Imaging Ltd
8.3.1.1 Overview
8.3.1.2 Products/ End-User
8.3.1.3 Strategy
8.3.1.4 Key Developments
8.3.2 Bruker Corporation
8.3.2.1 Overview
8.3.2.2 Products/ End-User
8.3.2.3 Strategy
8.3.2.4 Key Developments
8.3.3 Fujifilm Holdings Corporation
8.3.3.1 Overview
8.3.3.2 Products/ End-User
8.3.3.3 Strategy
8.3.3.4 Key Developments
8.3.4 Li-Cor Biosciences
8.3.4.1 Overview
8.3.4.2 Products/ End-User
8.3.4.3 Strategy
8.3.4.4 Key Developments
8.3.5 Mediso Ltd
8.3.5.1 Overview
8.3.5.2 Products/ End-User
8.3.5.3 Strategy
8.3.5.4 Key Developments
8.3.6 Milabs BV
8.3.6.1 Overview
8.3.6.2 Products/ End-User
8.3.6.3 Strategy
8.3.6.4 Key Developments
8.3.7 Miltenyi Biotec GmbH
8.3.7.1 Overview
8.3.7.2 Products/ End-User
8.3.7.3 Strategy
8.3.7.4 Key Development
8.3.8 MR Solutions Ltd
8.3.8.1 Overview
8.3.8.2 Products/ End-User
8.3.8.3 Strategy
8.3.8.4 Key Development
8.3.9 PerkinElmer Inc.
8.3.9.1 Overview
8.3.9.2 Products/ End-User
8.3.9.3 Strategy
8.3.9.4 Key Development
8.3.10 Trifoil Imaging
8.3.10.1 Overview
8.3.10.2 Products/ End-User
8.3.10.3 Strategy
8.3.10.4 Key Development
8.3.11 Bioscan
8.3.11.1 Overview
8.3.11.2 Products/ End-User
8.3.11.3 Strategy
8.3.11.4 Key Development
8.3.12 Mediso Medical Imaging Systems
8.3.12.1 Overview
8.3.12.2 Products/ End-User
8.3.12.3 Strategy
8.3.12.4 Key Development
8.3.13 Siemens Healthcare
8.3.13.1 Overview
8.3.13.2 Products/ End-User
8.3.13.3 Strategy
8.3.13.4 Key Development
8.3.14 Thermo Fisher Scientific
8.3.14.1 Overview
8.3.14.2 Products/ End-User
8.3.14.3 Strategy
8.3.14.4 Key Development
8.3.15 Agilent Technologies
8.3.15.1 Overview
8.3.15.2 Products/ End-User
8.3.15.3 Strategy
8.3.15.4 Key Development
8.3.16 Capintec
8.3.16.1 Overview
8.3.16.2 Products/ End-User
8.3.16.3 Strategy
8.3.16.4 Key Development
8.3.17 Hitachi Medical
8.3.17.1 Overview
8.3.17.2 Products/ End-User
8.3.17.3 Strategy
8.3.17.4 Key Development
8.3.18 Naviscan
8.3.18.1 Overview
8.3.18.2 Products/ End-User
8.3.18.3 Strategy
8.3.18.4 Key Development
8.3.19 Positron
8.3.19.1 Overview
8.3.19.2 Products/ End-User
8.3.19.3 Strategy
8.3.19.4 Key Development
8.3.20 Promega
8.3.20.1 Overview
8.3.20.2 Products/ End-User
8.3.20.3 Strategy
8.3.20.4 Key Development
8.3.21 Berthold Technologies
8.3.21.1 Overview
8.3.21.2 Products/ End-User
8.3.21.3 Strategy
8.3.21.4 Key Development
8.3.22 INDEC BioSystems
8.3.22.1 Overview
8.3.22.2 Products/ End-User
8.3.22.3 Strategy
8.3.22.4 Key Development
8.3.23 Hitachi Medical
8.3.23.1 Overview
8.3.23.2 Products/ End-User
8.3.23.3 Strategy
8.3.23.4 Key Development
8.3.24 Angstrom Advanced Inc.
8.3.24.1 Overview
8.3.24.2 Products/ End-User
8.3.24.3 Strategy
8.3.24.4 Key Development
8.3.25 Kubtec X-Ray
8.3.25.1 Overview
8.3.25.2 Products/ End-User
8.3.25.3 Strategy
8.3.25.4 Key Development

9 CONSOLIDATION
9.1 Global Pre-Clinical Imaging Market Share Analysis
9.1.1 Global Pre-Clinical Imaging Market Share Analysis by Modality 2019
9.1.2 Global Pre-Clinical Imaging Market Share Analysis by Reagents 2019
9.1.3 Global Pre-Clinical Imaging Market Share Analysis by Key Players 2019
9.2 Competitive Benchmarking of Key Players by Modality, Reagents and Geographical Presence by 2019
9.3 Comparative Analysis of Global Pre-Clinical Imaging Market by Geographies by 2019
9.4 Mergers and Acquisitions in the Industry through 2014 to 2018
9.4.1 Strategic alliances by geographies, technology, sales
9.5 Summary of Industry Consolidation
10 CONCLUSION
  • INQUIRE BEFORE BUYING